Cargando…
The Role of Calcineurin/NFAT in SFRP2 Induced Angiogenesis—A Rationale for Breast Cancer Treatment with the Calcineurin Inhibitor Tacrolimus
Tacrolimus (FK506) is an immunosuppressive drug that binds to the immunophilin FKBPB12. The FK506-FKBP12 complex associates with calcineurin and inhibits its phosphatase activity, resulting in inhibition of nuclear translocation of nuclear factor of activated T-cells (NFAT). There is increasing data...
Autores principales: | Siamakpour-Reihani, Sharareh, Caster, Joseph, Bandhu Nepal, Desh, Courtwright, Andrew, Hilliard, Eleanor, Usary, Jerry, Ketelsen, David, Darr, David, Shen, Xiang Jun, Patterson, Cam, Klauber-DeMore, Nancy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108822/ https://www.ncbi.nlm.nih.gov/pubmed/21673995 http://dx.doi.org/10.1371/journal.pone.0020412 |
Ejemplares similares
-
Balanced interactions of calcineurin with AKAP79 regulate Ca(2+)–calcineurin–NFAT signaling
por: Li, Huiming, et al.
Publicado: (2012) -
A polypeptide inhibitor of calcineurin blocks the calcineurin-NFAT signalling pathway in vivo and in vitro
por: Wang, Ping, et al.
Publicado: (2021) -
Calcineurin/NFAT signalling inhibits myeloid haematopoiesis
por: Fric, Jan, et al.
Publicado: (2012) -
Astrocyte Activation and the Calcineurin/NFAT Pathway in Cerebrovascular Disease
por: Kraner, Susan D., et al.
Publicado: (2018) -
MON-532 Characterization of the Angiogenic Factor SFRP2 in Papillary Thyroid Carcinoma
por: Wofford, Wyatt O, et al.
Publicado: (2020)